APN News

  • Thursday, August, 2019| Today's Market | Current Time: 08:53:38
  • District Court Decision Received in NPWT Patent Litigation

    United States: The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. (NYSE:KCI), Wake Forest University and Smith & Nephew, Inc. The Court held that the patent claims licensed by KCI from Wake Forest University and asserted in this litigation are invalid. KCI […]

    Biocon and Pfizer Enter into Global Commercialization Agreement

    Bangalore: Biocon, Asia’s premier biotechnology company, and Pfizer, the world’s leading biopharmaceutical company, today announced that they have entered into a strategic global agreement for the worldwide commercialization of Biocon’s biosimilar versions of Insulin and Insulin analog products: Recombinant Human Insulin, Glargine, Aspart and Lispro. Pfizer will have exclusive rights to commercialize these products globally, […]

    Celgene Completes Acquisition of Abraxis

    Celgene Corporation (NASDAQ: CELG) has announced it has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders will receive (i) $58.00 in cash (ii) 0.2617 shares of Celgene common stock, and (iii) one tradeable Contingent Value Right (CVR), which entitles its holder to receive a pro rata share […]

    World Health Organisation’s Tobacco Guidelines Will “Promote Poverty and Starvation in Africa”

    African tobacco growing countries have spoken out unanimously against the World Health Organisation (WHO) saying the proposed ban on the use of ingredients in the manufacture of tobacco products would actively promote poverty. Meeting at a conference in Lusaka, Zambia delegates from 11 African countries, including Zambia, Zimbabwe, Tanzania, Mozambique, Malawi, Uganda, Madagascar, Swaziland, Cote […]

    GSK Increases Support For WHO Strategy to Improve Children’s Health

    London : At the launch of the World Health Organization’s (WHO) first report on Neglected Tropical Diseases today, GSK announced a new five year commitment to expand the donation of its medicine albendazole to treat children at risk of intestinal worms, known as soil-transmitted helminths (STH). Today’s report confirms that intestinal worms cause more ill […]

    pinkWhale Healthcare Services Introduces Diagnostics Services

    Bangalore : pinkWhale Healthcare Services, announced today, that residents in select metros can now avail diagnostic services like getting blood and urine tests done, from the convenience of their homes. On the occasion Anita Shet, CEO, pinkWhale Healthcare Services said, “With constraints on our time, many of us keep putting off a blood test or […]

    European Medicines Agency approves TWYNSTA

    Germany :Boehringer Ingelheim announced  that the European Commission confirmed the positive opinion of the European Medicines Agency (EMA) approving TWYNSTA. TWYNSTA is indicated for the treatment of hypertension in adults whose blood pressure is not adequately controlled on amlodipine or as replacement therapy in adult patients receiving telmisartan and amlodipine from separate tablets containing the […]

    Aetna Announces New Managing Director Appointments in Asia Pacific

    London : Aetna (NYSE: AET), a leading global diversified health care benefits company, announced today that Hocking Cheng and Derek Goldberg have been named to the new positions of managing director, Greater China and managing director, Southeast Asia, respectively. In these roles, Cheng and Goldberg will develop and execute growth strategies to further expand the […]

    Early Tumor Shrinkage with 1st Line Erbitux Therapy Leads to Longest-Ever Median Survival in KRAS Wild-Type mCRC

    Merck Serono, a division of Merck KGaA,Darmstadt,Germany has announced that new data presented today at the 35th Congressof the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux® (cetuximab) based treatment lived a median of […]

    PPD Opens New Office in Beijing, China

    United States: PPD, Inc. has announced it has consolidated its clinical development operations in Beijing, China, in a new, larger office to support its growing client base in the country and throughout Asia Pacific. The new location enhances PPD’s ability to deliver a full range of clinical research and development services in China as one […]